Normal-tissue toxicities of thoracic radiation therapy: esophagus, lung, and spinal cord as organs at risk
Tóm tắt
Từ khóa
Tài liệu tham khảo
Phillips, 1974, Time-dose relationships in the mouse esophagus, Radiology, 113, 435, 10.1148/113.2.435
Goldstein, 1975, Radiological manifestations of radiation-induced injury to the normal upper gastrointestinal tract, Radiology, 117, 135, 10.1148/117.1.135
Lepke, 1983, Radiation-induced injury of the esophagus, Radiology, 148, 375, 10.1148/radiology.148.2.6867327
Werner-Wasik, 2002, Proc Am Soc Clin Oncol, 21, 299a
Cox, 1993, Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 RTOG trials, Int J Radiat Oncol Biol Phys, 27, 493, 10.1016/0360-3016(93)90371-2
Hirota, 2001, Endoscopic findings of radiation esophagitis in concurrent chemoradiotherapy for intrathoracic malignancies, Radiother Oncol, 58, 273, 10.1016/S0167-8140(00)00274-7
Werner-Wasik, 2001, Preliminary report on reduction of esophagitis by amifostine in patients with non-small-cell lung cancer treated with chemoradiotherapy, Clin Lung Cancer, 2, 284, 10.3816/CLC.2001.n.011
Werner-Wasik, 2002, Phase II trial of twice weekly amifostine in patients with non-small cell lung cancer treated with chemotherapy, Semin Radiat Oncol, 12, 34, 10.1053/srao.2002.31361
Rowland, 1995, Assessment of area under the curve, 469
Movsas, 2002, Exploring the role of the radioprotector amifostine in locally advanced non-small cell lung cancer: Radiation Therapy Oncology Group trial 98–01, Semin Radiat Oncol, 12, 40, 10.1053/srao.2002.31362
Gaspar, 2001, Consolidation docetaxel following concurrent chemoradiotherapy in pathologic stage IIIb non-small cell lung cancer (NSCLC) (SWOG 9504): patterns of failure and updated survival [abstract], Proc Am Soc Clin Oncol, 20, 315a
Curran, 2000, Phase III comparison of sequential vs. concurrent chemoradiation for patients with unresected stage III non-small cell lung cancer: initial report of RTOG 9410 [abstract], Proc Am Soc Clin Oncol, 19, 484a
Furuse, 1999, Phase III study of concurrent vs. sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small cell lung cancer, J Clin Oncol, 17, 2692, 10.1200/JCO.1999.17.9.2692
Boal, 1979, Esophagitis induced by combined radiation and adriamycin, AJR Am J Roentgenol, 132, 567, 10.2214/ajr.132.4.567
Vokes, 1999, A randomized phase II study of gemcitabine or paclitaxel or vinorelbine with cisplatin as induction chemotherapy and concomitant chemoradiotherapy for unresectable stage III non-small cell lung cancer (NSCLC) [abstract], Proc Am Soc Clin Oncol, 18, 459a
Werner-Wasik, 2000, Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: a multivariate analysis of patients with lung cancer treated with non-operative therapy, Int J Radiat Oncol Biol Phys, 48, 689, 10.1016/S0360-3016(00)00699-4
Ball, 1995, A phase III study of accelerated radiotherapy with and without carboplatin in non-small cell lung cancer: an interim toxicity analysis of the first 100 patients, Int J Radiat Oncol Biol Phys, 31, 267, 10.1016/0360-3016(94)E0021-B
Choy, 1999, Esophagitis in combined modality therapy for locally advanced non-small cell lung cancer, Sem Rad Oncol, 9, 90
Langer, 1999, Concurrent chemoradiation using pacltaxel and carboplatin in locally advanced non-small cell lung cancer, Sem Rad Oncol, 9, 108
Michalowski, 1986, Assays of damage to the alimentary canal, Br J Cancer, 53, 1
Dubray, 1995, Combined chemoradiation for locally advanced non-small cell lung cancer, J Infus Chemother, 5, 195
Saunders, 1996, Randomized multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small cell lung cancer: an interim report, Br J Cancer, 73, 1455, 10.1038/bjc.1996.276
Byhardt, 1998, Response, toxicity, failure patterns, and survival in five RTOG trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small cell carcinoma of the lung, Int J Radiat Oncol Biol Phys, 42, 469, 10.1016/S0360-3016(98)00251-X
Werner-Wasik, 1999, Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy: a multivariate analysis of 1076 RTOG patients, Int J Radiat Oncol Biol Phys, 44, 327, 10.1016/S0360-3016(99)00031-0
Umsawasdi, 1985, Esophageal complications from combined chemoradiotherapy (cyclophosphamide + adriamycin + cisplatin + XRT) in the treatment of non-small cell lung cancer, Int J Rad Oncol Biol Phys, 11, 511, 10.1016/0360-3016(85)90182-8
Emami, 1996, Three-dimensional conformal radiation therapy in bronchogenic carcinoma, Semin Radiat Oncol, 6, 92, 10.1016/S1053-4296(96)80005-1
Maguire, 1999, Clinical and dosimetric predictors of radiation-induced esophageal toxicy, Int J Radiat Oncol Biol Phys, 45, 97, 10.1016/S0360-3016(99)00163-7
Hirota, 2001, Dosimetric predictors of radiation esophagitis in patients treated for non-small cell lung cancer with carboplatin/paclitaxel radiotherapy, Int J Radiat Oncol Biol Phys, 51, 291, 10.1016/S0360-3016(01)01648-0
Singh, 2003, Predictors of radiation-induced esophageal toxicity in patients with non-small cell lung cancer treated with three-dimensional conformal radiotherapy, Int J Radiat Oncol Biol Phys, 55, 337, 10.1016/S0360-3016(02)03937-8
Fletcher, 1973, Clinical dose-response curves of human malignant epithelial tumors, Br J Radiol, 46, 1, 10.1259/0007-1285-46-541-1
Hayman, 2001, Dose escalation in non-small cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial, J Clin Oncol, 19, 127, 10.1200/JCO.2001.19.1.127
Graham, 1994, Three-dimensional radiation treatment planning study for patients with carcinoma of the lung, Int J Radiat Oncol Biol Phys, 29, 1105, 10.1016/0360-3016(94)90407-3
DeGersem, 2000, Optimization of beam weights in conformal radiotherapy planning of stage III non-small cell lung cancer: effects on the therapeutic ratio, Int J Radiat Oncol Biol Phys, 47, 255, 10.1016/S0360-3016(99)00332-6
Derycke, 1998, Conformal radiotherapy of stage III non-small cell lung cancer: a class solution involving non-coplanar intensity-modulated beams, Int J Radiat Oncol Biol Phys, 41, 771, 10.1016/S0360-3016(98)00114-X
Xiao, 2002
Emami, 1996, The value of regional nodal radiotherapy (dose/volume) in the treatment of unresectable non-small cell lung cancer: an RTOG analysis, Int J Radiat Oncol Biol Phys, 36, 209, 10.1016/S0360-3016(97)85443-0
Emami, 1991, Tolerance of normal tissue to therapeutic irradiation, Int J Radiat Oncol Biol Phys, 21, 109, 10.1016/0360-3016(91)90171-Y
Brizel, 2000, Phase III randomized trial of amifostine as a radioprotector in head and neck cancer, J Clin Oncol, 18, 3339, 10.1200/JCO.2000.18.19.3339
Ito, 1986, Protection of acute and late radiation damage of the gastrointestinal tract by WR-2721, Int J Radiat Oncol Biol Phys, 12, 211, 10.1016/0360-3016(86)90096-9
Koukourakis, 1996, The impact of overall treatment time on the results of radiotherapy for non-small cell lung carcinoma, Int J Radiat Oncol Biol Phys, 34, 315, 10.1016/0360-3016(95)02102-7
Antonadou, 2001, Randomized phase III trial of radiation treatment plus/minus amifostine in patients with advanced-stage lung cancer, Int J Radiat Oncol Biol Phys, 51, 915, 10.1016/S0360-3016(01)01713-8
Komaki, 2002, Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage I–III non-small cell lung cancer: preliminary results, Semin Radiat Oncol, 12, 46
McGinnis, 1997, Placebo-controlled trial of sucralfate for inhibiting radiation-induced esophagitis, J Clin Oncol, 15, 1239, 10.1200/JCO.1997.15.3.1239
Stickle, 1999, Prevention of irradiation-induced esophagitis by plasmid/liposome delivery of the human manganese superoxide dismutase transgene, Radiat Oncol Invest, 7, 204, 10.1002/(SICI)1520-6823(1999)7:4<204::AID-ROI2>3.0.CO;2-S
Spielberegr, 2001, Proc Am Soc Clin Oncol, 20, 7
Favaretto, 1996, Pre-operative chemoradiotherapy in non-small cell lung cancer stage III patients. Feasibility, toxicity and long-term results of a phase II study, Eur J Cancer, 32A, 2064, 10.1016/S0959-8049(96)00248-1
Segawa, 1997, Risk factors for development of radiation pneumonitis following radiation therapy with or without chemotherapy for lung cancer, Int J Radiat Oncol Biol Phys, 39, 91, 10.1016/S0360-3016(97)00297-6
Fu, 1997, Hyperfractionated accelerated radiation therapy for non-small cell lung cancer: clinical phase I/II trial, Int J Radiat Oncol Biol Phys, 39, 545, 10.1016/S0360-3016(97)00332-5
Monson, 1998, Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma, Cancer, 82, 842, 10.1002/(SICI)1097-0142(19980301)82:5<842::AID-CNCR7>3.0.CO;2-L
Yamada, 1998, Risk factors of pneumonitis following chemoradiotherapy for lung cancer, Eur J Cancer, 34, 71, 10.1016/S0959-8049(97)00377-8
Nyman, 1998, Accelerated hyperfractionated radiotherapy combined with induction and concomitant chemotherapy for inoperable non-small-cell lung cancer, Acta Oncol (Madr), 37, 539, 10.1080/028418698430232
Van den Brande, 1998, Sequential treatment with vindesine-ifosfamide-platinum (VIP) chemotherapy followed by platinum sensitized radiotherapy in stage IIIB non-small cell lung cancer: a phase II trial, Lung Cancer, 22, 45, 10.1016/S0169-5002(98)00071-3
Makimoto, 1998, Risk factors for severe radiation pneumonitis in lung cancer, Jpn J Clin Oncol, 29, 192, 10.1093/jjco/29.4.192
Graham, 1999, Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC), Int J Radiat Oncol Biol Phys, 45, 323, 10.1016/S0360-3016(99)00183-2
Robnett, 2000, Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer, Int J Radiat Oncol Biol Phys, 48, 89, 10.1016/S0360-3016(00)00648-9
Sunyach, 2000, Prospective evaluation of early lung toxicity following three-dimensional conformal radiation therapy in non-small-cell lung cancer: preliminary results, Int J Radiat Oncol Biol Phys, 48, 459, 10.1016/S0360-3016(00)00618-0
Inoue, 2001, Radiation pneumonitis in lung cancer patients: a retrospective study of risk factors and the long-term prognosis, Int J Radiat Oncol Biol Phys, 49, 649, 10.1016/S0360-3016(00)00783-5
Hernando, 2001, Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer, Int J Radiat Oncol Biol Phys, 51, 650, 10.1016/S0360-3016(01)01685-6
Oetzel, 1995, Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis, Int J Radiat Oncol Biol Phys, 33, 455, 10.1016/0360-3016(95)00009-N
Perry, 1987, Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung, N Engl J Med, 316, 912, 10.1056/NEJM198704093161504
Gross, 1977, Pulmonary effects of radiation therapy, Ann Intern Med, 86, 81, 10.7326/0003-4819-86-1-81
Simpson, 1985, Palliative radiotherapy for inoperable carcinoma of the lung: final report of a RTOG multi-institutional trial, Int J Radiat Oncol Biol Phys, 11, 751, 10.1016/0360-3016(85)90307-4
Kwon, 2000, Effect of pentoxifylline on radiation response of non-small cell lung cancer: a phase III randomized multicenter trial, Radiother Oncol, 56, 175, 10.1016/S0167-8140(00)00221-8
Perez, 1980, A prospective randomized study of various radiation doses and fractionation schedules in the treatment of inoperable non-small cell carcinoma of the lung, Cancer, 45, 2744, 10.1002/1097-0142(19800601)45:11<2744::AID-CNCR2820451108>3.0.CO;2-U
Martel, 1994, Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis, Int J Radiat Oncol Biol Phys, 28, 575, 10.1016/0360-3016(94)90181-3
Choi, 1990, Effect of post-operative radiotherapy on changes in pulmonary function in patients with stage II and IIIa lung carcinoma, Int J Radiat Oncol Biol Phys, 18, 95, 10.1016/0360-3016(90)90272-L
Brady, 1965, The effects of radiation therapy on pulmonary function in carcinoma of the lung, Radiology, 85, 130, 10.1148/85.1.130
Bentzen, 1996, Radiotherapy-related lung fibrosis enhanced by Tamoxifen, J Nat Cancer Inst, 88, 918, 10.1093/jnci/88.13.918
Levinson, 1998, Regional dose response to pulmonary irradiation using a manual method, Radiother Oncol, 48, 53, 10.1016/S0167-8140(98)00057-7
Marks, 1994, The pulmonary effects of thoracic irradiation, Oncology, 8, 89
Morgan, 1995, Radiation and the lung: a reevaluation of the mechanisms mediating pulmonary injury, Int J Radiat Oncol Biol Phys, 31, 361, 10.1016/0360-3016(94)00477-3
Abid, 2001, Radiation-induced and chemotherapy-induced pulmonary injury, Curr Opin Oncol, 13, 242, 10.1097/00001622-200107000-00006
Garipagaoglu, 1999, The effect of patient-specific gactors on tadiation induced regional lung injury, Int J Radiat Oncol Biol Phys, 45, 331, 10.1016/S0360-3016(99)00201-1
Maguire, 2001, 73.6 Gy and beyond: hyperfractionated, accelerated radiotherapy for non-small-cell lung cancer, J Clin Oncol, 19, 705, 10.1200/JCO.2001.19.3.705
Dechambre, 1998, Bronchial stenosis and sclerosing mediastintis: an uncommon complication of external thoracic rediotherapy, Eur Respir J, 11, 1188, 10.1183/09031936.98.11051188
von der Maase, 1986, Effect of cancer chemotherapeutic drugs on radiation-induced lung damage in mice, Radiother Oncol, 5, 245, 10.1016/S0167-8140(86)80054-8
Sause, 1995, Radiation Therapy Oncology Group (RTOG) 88–08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer, J Natl Cancer Inst, 87, 198, 10.1093/jnci/87.3.198
Clamon, 1999, Radiosensitization with carboplatin for patients with unresectable stage III non-small-cell lung cancer: a phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group, J Clin Oncol, 17, 4, 10.1200/JCO.1999.17.1.4
Furuse, 1999, Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer, J Clin Oncol, 17, 2692, 10.1200/JCO.1999.17.9.2692
Schaake-Koning, 1992, Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer, N Engl J Med, 326, 524, 10.1056/NEJM199202203260805
Mattson, 1987, Radiation pneumonitis and fibrosis following split-course radiation therapy for lung cancer: a radiologic and physiologic study, Acta Oncol, 26, 193, 10.3109/02841868709091430
Rubenstein, 1988, Prospective prediction of post-radiation therapy lung function using quantitative lung scans and pulmonary function testing, Int J Radiat Oncol Biol Phys, 15, 83, 10.1016/0360-3016(88)90350-1
Robert, 1999, Phase I/IIa study of concurrent paclitaxel and cisplatin with radiation therapy in locally advanced non-small cell lung cancer: analysis of early and late pulmonary morbidity, Semin Ratiat Oncol, 9, 136
Bonnet, 2001, Effects of proton and combined proton/ photon beam radiation on pulmonary function on patients with resectable but medically inoperable non-small cell lung cancer, Chest, 120, 1803, 10.1378/chest.120.6.1803
Rosen, 2001, Correlation between lung fibrosis and radiation therapy dose after concurrent radiation therapy and chemotherapy for limited small cell lung cancer, Radiology, 221, 614, 10.1148/radiol.2213992043
Trask, 1985, Radiation-induced lung fibrosis after treatment of small cell carcinoma of the lung with very high-dose cyclophosphamide, Cancer, 55, 57, 10.1002/1097-0142(19850101)55:1<57::AID-CNCR2820550110>3.0.CO;2-L
Woel, 2002, The time course of radiation therapy-induced reductions in regional perfusion: a prospective study with > 5 years of follow-up, Int J Radiat Oncol Biol Phys, 52, 58, 10.1016/S0360-3016(01)01809-0
Seppenwoolde, 2000, Radiation dose-effect relations and local recovery in perfusion for patients with non-small-cell lung cancer, Int J Radiat Oncol Biol Phys, 47, 681, 10.1016/S0360-3016(00)00454-5
Yorke, 2002, Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small cell lung cancer patients treated with three-dimensional conformal radiation therapy, Int J Radiat Oncol Biol Phys, 54, 329, 10.1016/S0360-3016(02)02929-2
Lind, 2002, Receiver operator curves (ROC) analysis of predictors for radiation-induced symptomatic lung injury, Int J Radiat Oncol Biol Phys, 54, 340, 10.1016/S0360-3016(02)02932-2
Anscher, 1998, Plasma transforming growth factor β1 as a predictor of radiation pneumonitis, Int J Radiat Onc Biol Phys, 41, 1029, 10.1016/S0360-3016(98)00154-0
Chen, 2002, Radiation pneumonitis and early circulatory cytokine markers, Semin Radiat Oncol, 12, 26, 10.1053/srao.2002.31360
Haston, 1997, Murine susceptibility to radiation-induced pulmonary fubrosis is induced by a genetic factor implicated in susceptibility to bleomycin-induced pulmonary fibrosis, Cancer Res, 57, 5286
Schultheiss, 1986, Survival in radiation myelopathy, Int J Radiat Oncol Biol Phys, 12, 1765, 10.1016/0360-3016(86)90317-2
Holdorff, 1980, Dose effect relationships in cervical and thoracic radiation myelopathies, Acta Radiologica Oncol, 19, 271, 10.3109/02841868009130164
Schultheiss, 1984, The latent period in clinical radiation myelopathy, Int J Radiat Oncol Biol Phys, 10, 1109, 10.1016/0360-3016(84)90184-6
Feldmann, 1986, Episodic neurologic dysfunction in patients with Hodgkin's disease, Arch Neurol, 43, 1227, 10.1001/archneur.1986.00520120011009
Chouchair, 1991, Myelopathies in the cancer patient: incidence, presentation, diagnosis and management, Oncology, 5, 25
Zulch, 1974, Delayed spinal radionecrosis—a juridical error?, Neuroradiology, 8, 173, 10.1007/BF00341598
Abadir, 1980, Radiation myelitis: can diagnosis be unequivocal without histological evidence?, Int J Radiat Oncol Biol Phys, 6, 649, 10.1016/0360-3016(80)90398-3
Lechevalier, 1973, Myelopathies radiotherapiques “hypertrophiantes” a propos de cinq observations dont une anatomo-clinique, Revue Neurologique Paris, 129, 119
Marty, 1973, Radiation myelitis simulating tumor, Arch Neurol, 29, 352, 10.1001/archneur.1973.00490290092015
Kitamura, 1979, Delayed radiation myelopathy, Yokohama Med Bull, 30, 61
Worthington, 1979, Diffuse cord enlargement in radiation myelopathy, Clin Radiol, 30, 117, 10.1016/S0009-9260(79)80062-8
Dorfman, 1982, Electrophysiologic evidence of subclinical injury to the posterior columns of the human spinal cord after therapeutic radiation, Cancer, 50, 2815, 10.1002/1097-0142(19821215)50:12<2815::AID-CNCR2820501221>3.0.CO;2-P
Snooks, 1985, Motor conduction velocity in the human spinal cord: slowed conduction in multiple sclerosis and radiation myelopathy, J Neurol Neurosurg Psychiatry, 48, 1135, 10.1136/jnnp.48.11.1135
Wang, 1992, MR imaging in radiation myelopathy, AJNR Am J Neuroradiol, 13, 1049
Schultheiss, 1988, Analysis of the histopathology of radiation myelopathy, Int J Radiat Oncol Biol Phys, 14, 27, 10.1016/0360-3016(88)90046-6
van der Kogel, 1991, The nervous system: radiobiology and experimental pathology, 191
Calvo, 1988, Time and dose-related changes in the white matter of the rat brain after single doses of X-rays, Br J Radiol, 61, 1043, 10.1259/0007-1285-61-731-1043
Reinhold, 1990, Development of blood vessel-related radiation damage in the fimbria of the central nervous system, Int J Radiat Oncol Biol Phys, 18, 37, 10.1016/0360-3016(90)90264-K
Hubbard, 1979, Changes in the neuroglial cell populations of the rat spinal cord after local X-irradiation, Br J Radiol, 52, 816, 10.1259/0007-1285-52-622-816
Myers, 1986, Reappraisal of the roles of glial and vascular elements in the development of white matter necrosis in irradiated rat spinal cord, Br J Cancer, 53, 221
Baekmark, 1975, Neurologic complications after irradiation of the cervical spinal cord for malignant tumour of the head and neck, Acta Radiol Ther Phys Biol, 14, 33, 10.3109/02841867509132259
Kim, 1981, Radiation tolerance of the cervical spinal cord, Radiology, 139, 473, 10.1148/radiology.139.2.7220892
Kramer, 1968, The hazards of therapeutic irradiation of the central nervous system, Clin Neurosurg, 15, 301, 10.1093/neurosurgery/15.CN_suppl_1.301
Marks, 1972, Increased rate of complication as a result of treating only one prescribed field daily, Radiology, 107, 615, 10.1148/107.3.615
Schultheiss, 1995, Radiation response of the central nervous system, Int J Radiat Oncol Biol Phys, 31, 1093, 10.1016/0360-3016(94)00655-5
Schultheiss, 1999, The radiation dose response of the human cervical spinal cord, Int J Radiat Oncol Biol Phys, 45, 174, 10.1016/S0360-3016(99)90072-X
Schultheiss, 1990, Radiation myelopathy in primates treated with conventional fractionation, Int J Radiat Oncol Biol Phys, 19, 935, 10.1016/0360-3016(90)90015-C
Knowles, 1983, The radiosensitivity of the guinea pig spinal cord to X-rays: the effect of retreatment at one year and the effect of age at the time of irradiation, Int J Radiat Biol, 44, 433, 10.1080/09553008314551411
Dische, 1989, Continuous hyperfractionated accelerated radiotherapy (CHART): an interim report upon late morbidity, Radioth Oncol, 16, 67, 10.1016/0167-8140(89)90071-6
Wong, 1991, Myelopathy following hyperfractionated accelerated radiotherapy for anaplastic thyroid carcinoma, Radiother Oncol, 20, 3, 10.1016/0167-8140(91)90105-P
Thames, 1989, Repair kinetics in tissues: alternative models, Radiother Oncol, 14, 321, 10.1016/0167-8140(89)90144-8
Thames, 1988, Does incomplete repair explain the apparent failure of the basic LQ model to predict spinal cord and kidney responses to low doses per fraction?, Int J Radiat Biol, 55, 27
Marcus, 1990, The incidence of myelitis after irradiation of the cervical spinal cord, Int J Radiat Oncol Biol Phys, 19, 3, 10.1016/0360-3016(90)90126-5
Ang, 1983, The effect of small radiation doses on the rat spinal cord: the concept of partial tolerance, Int J Radiat Oncol Biol Phys, 9, 1487, 10.1016/0360-3016(83)90323-1
Hornsey, 1980, Isoeffect curve for radiation myelopathy, Br J Radiol, 53, 168, 10.1259/0007-1285-53-626-168
Masuda, 1977, Dose effect relationship for epilation and late effects on spinal cord in rats exposed to gamma rays, Radiology, 122, 239, 10.1148/122.1.239
van der Kogel, 1977, Radiation tolerance of the rat spinal cord: time-dose relationships, Radiology, 122, 505, 10.1148/122.2.505
van der Kogel, 1991, Central nervous system radiation injury in small animal models, 91
Wong, 1992, Linear-quadratic model underestimates sparing effect of small doses per fraction in rat spinal cord, Radiother Oncol, 23, 176, 10.1016/0167-8140(92)90328-R
Stephens, 1983, Late effects of 50 MeV d leads to Be neutron and cobalt-60 irradiation of rhesus monkey cervical spinal cord, Int J Radiat Oncol Biol Phys, 9, 859, 10.1016/0360-3016(83)90012-3
Schultheiss, 1994, Volume effects in rhesus monkey spinal cord, Int J Radiat Oncol Biol Phys, 29, 67, 10.1016/0360-3016(94)90227-5
Schultheiss, 1992, Neutron RBE for primate spinal cord treated with clinical regimens, Radiat Res, 129, 212, 10.2307/3578159
Austin, 1993, Probable causes of recurrence in patients with chordoma and chondrosarcoma of the base of skull and cervical spine, Int J Radiat Oncol Biol Phys, 25, 439, 10.1016/0360-3016(93)90065-4
Ang, 2001, Extent and kinetics of recovery of occult spinal cord injury, Int J Radiat Oncol Biol Phys, 50, 1013, 10.1016/S0360-3016(01)01599-1
Coy, 1971, Radiation myelopathy in relation to oxygen level, Br J Radiol, 44, 705, 10.1259/0007-1285-44-525-705
van den Brenk, 1968, Radiosensitivity of the human spinal cord based on analysis of 357 cases receiving 4 MeV X rays in hyperbaric oxygen, Br J Radiol, 41, 205, 10.1259/0007-1285-41-483-205
Dische, 1986, Hemoglobin, radiation, morbidity and survival, Int J Radiat Oncol Biol Phys, 12, 1335, 10.1016/0360-3016(86)90166-5
Asscher, 1992, Arterial hypertension and irradiation damage to the nervous system, Lancet, ii, 1343
Hopewell, 1970, The nature of latent cerebral irradiation damage and its modification by hypertension, Br J Radiol, 43, 161, 10.1259/0007-1285-43-507-161
Bradley, 2003, Acute and late toxicity results of RTOG 9311: a dose escalation study using 3D conformal radiation therapy in patients with inoperable non-small cell lung cancer, Int J Radiat Oncol Biol Phys, 57, S137, 10.1016/S0360-3016(03)00846-0